The Motley Fool·6h ago·David Jagielski, CpaTilray's U.S. Pot Dream Faces Long Road Despite Rescheduling VictoryCannabis rescheduling offers hope but legalization remains years away. Tilray investors shouldn't bet on near-term U.S. market entry. TLRYstock performanceinvestment risk